应重视实时震动诱导转化技术在克-雅病临床诊断中的应用

doi:10.3969/j.issn.1672-6731.2023.04.001

中国现代神经疾病杂志 ›› 2023, Vol. 23 ›› Issue (4): 271-274. doi: 10.3969/j.issn.1672-6731.2023.04.001

2 应重视实时震动诱导转化技术在克-雅病临床诊断中的应用

贺电

550004 贵阳, 贵州医科大学附属医院神经内科

收稿日期:2023-04-18 出版日期:2023-04-25 发布日期:2023-05-08
通讯作者: 贺电,Email:hedian@gmc.edu.cn
基金资助:
科技创新2030-“脑科学与类脑研究”重大项目（项目编号：2021ZD0201801）；贵州省卫生健康委员会科学技术基金资助项目（项目编号：gzwkj2021-018）

Application value of real-time quaking-induced conversion technology in clinical diagnosis of Creutzfeldt-Jakob disease

HE Dian

Department of Neurology, The Affiliated Hospital of Guizhou Medical University, Guiyang 550004, Guizhou, China

Received:2023-04-18 Online:2023-04-25 Published:2023-05-08
Supported by:
This study was supported by Science and Technology Innovation 2030 "Brain Science and Brain-like Research" Major Project (No. 2021ZD0201801), and Science and Technology Foundation of Guizhou Health Commission (No. gzwkj2021-018).

摘要/Abstract

摘要： 克-雅病是一组由朊蛋白错误折叠引起的临床罕见的神经系统变性疾病，是人类朊病毒病的最常见类型。自20世纪70年代朊病毒特征被认识以来，诊断性检测技术取得长足进展，尤以实时震动诱导转化（RT-QuIC）技术最为突出。本文阐述克-雅病发病机制，RT-QuIC技术作用机制及其在克-雅病诊断中的应用现状，以期促进RT-QuIC技术在我国克-雅病领域的应用与发展。

关键词: 克-亚综合征, 朊病毒, 诊断, 综述

Abstract: Creutzfeldt-Jakob disease (CJD) is a group of clinically rare neurodegenerative diseases caused by misfolding of prion proteins, and is the most common type of human prion diseases. Since the prion characteristics were recognized in the 1970s, the diagnostic detection technology has made great progress, especially the real-time quaking-induced conversion (RT-QuIC). This paper describes the pathogenesis of CJD, the mechanism of action of RT-QuIC and its application in the diagnosis of CJD in order to promote the application and development of RT-QuIC technology in the field of CJD.

Key words: Creutzfeldt-Jakob syndrome, Prions, Diagnosis, Review

贺电. 应重视实时震动诱导转化技术在克-雅病临床诊断中的应用[J]. 中国现代神经疾病杂志, 2023, 23(4): 271-274.

HE Dian. Application value of real-time quaking-induced conversion technology in clinical diagnosis of Creutzfeldt-Jakob disease[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2023, 23(4): 271-274.

https://journal11.magtechjournal.com/cjcnn/CN/Y2023/V23/I4/271

参考文献

[1] Gomes Mda M. Creutzfeldt-Jakob disease:one hundred years of participation in the design of the transmissible spongiform encephalopathies[J]. Rev Bras Neurol, 2020, 56:25-28.
[2] Zerr I. Laboratory diagnosis of Creutzfeldt-Jakob disease[J]. N Engl J Med, 2022, 386:1345-1350.
[3] Institute of Viral Disease Prevention and Control, Chinese Center for Disease Control and Prevention. Establishment of the diagnosis and surveillance system for human prion diseases in China and the relevant basic and applied studies[DB/OL]. Beijing:Chinese Center for Disease Control and Prevention. 2011(2011-04-26)[2023-04-10]. https://www.chinacdc.cn/kjxm/kjcg/201104/t20110426_42273.htm.[中国疾病预防控制中心病毒病预防控制所. 我国人类朊病毒病检测监测体系建立及相关基础和应用研究[DB/OL]. 北京:中国疾病预防控制中心. 2011(2011-04-26)[2023-04-10]. https://www.chinacdc.cn/kjxm/kjcg/201104/t20110426_42273.htm.]
[4] Neuroinfectious Diseases and Cerebrospinal Fluid Cytology, Neurology Branch, Chinese Medical Association. Chinese guidelines for diagnosis of Creutzfeldt-Jakob disease 2021[J]. Zhonghua Shen Jing Ke Za Zhi, 2022, 55:1215-1224.[中华医学会神经病学分会神经感染性疾病与脑脊液细胞学学组. 克-雅病中国诊断指南2021[J]. 中华神经科杂志, 2022, 55:1215-1224.]
[5] Dong XP, Han J, Chen C, Shi Q, Wang DX, Gao C, Tian C, Xia SL, Li XH, Zhang XC. WS/T 562-2017 Creutzfeldt-Jakob disease[S]. Beijing:National Health and Family Planning Commission, 2017.[董小平, 韩俊, 陈操, 石琦, 王得新, 高晨, 田婵, 夏胜利, 李洵桦, 张秀春. WS/T 562-2017克-雅病诊断[S]. 北京:国家卫生和计划生育委员会, 2017.]
[6] Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease[J]. Brain, 2009, 132(Pt 10):2659-2668.
[7] Green AJE. RT-QuIC:a new test for sporadic CJD[J]. Pract Neurol, 2019, 19:49-55.
[8] Groveman BR, Orrú CD, Hughson AG, Bongianni M, Fiorini M, Imperiale D, Ladogana A, Pocchiari M, Zanusso G, Caughey B. Extended and direct evaluation of RT-QuIC assays for Creutzfeldt-Jakob disease diagnosis[J]. Ann Clin Transl Neurol, 2016, 4:139-144.
[9] Foutz A, Appleby BS, Hamlin C, Liu X, Yang S, Cohen Y, Chen W, Blevins J, Fausett C, Wang H, Gambetti P, Zhang S, Hughson A, Tatsuoka C, Schonberger LB, Cohen ML, Caughey B, Safar JG. Diagnostic and prognostic value of human prion detection in cerebrospinal fluid[J]. Ann Neurol, 2017, 81:79-92.
[10] Lattanzio F, Abu-Rumeileh S, Franceschini A, Kai H, Amore G, Poggiolini I, Rossi M, Baiardi S, McGuire L, Ladogana A, Pocchiari M, Green A, Capellari S, Parchi P. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease:diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels[J]. Acta Neuropathol, 2017, 133:559-578.
[11] Fiorini M, Iselle G, Perra D, Bongianni M, Capaldi S, Sacchetto L, Ferrari S, Mombello A, Vascellari S, Testi S, Monaco S, Zanusso G. High diagnostic accuracy of RT-QuIC assay in a prospective study of patients with suspected sCJD[J]. Int J Mol Sci, 2020, 21:880.
[12] Shir D, Lazar EB, Graff-Radford J, Aksamit AJ, Cutsforth-Gregory JK, Jones DT, Botha H, Ramanan VK, Prusinski C, Porter A, Day GS. Analysis of clinical features, diagnostic tests, and biomarkers in patients with suspected Creutzfeldt-Jakob disease, 2014-2021[J]. JAMA Netw Open, 2022, 5:e2225098.
[13] Watson N, Hermann P, Ladogana A, Denouel A, Baiardi S, Colaizzo E, Giaccone G, Glatzel M, Green AJE, Haïk S, Imperiale D, MacKenzie J, Moda F, Smith C, Summers D, Tiple D, Vaianella L, Zanusso G, Pocchiari M, Zerr I, Parchi P, Brandel JP, Pal S. Validation of revised international Creutzfeldt-Jakob disease surveillance network diagnostic criteria for sporadic Creutzfeldt-Jakob disease[J]. JAMA Netw Open, 2022, 5:e2146319.
[14] Hermann P, Schmitz M, Cramm M, Goebel S, Bunck T, Schütte-Schmidt J, Schulz-Schaeffer W, Stadelmann C, Matschke J, Glatzel M, Zerr I. Application of real-time quaking-induced conversion in Creutzfeldt-Jakob disease surveillance[J]. J Neurol, 2023, 270:2149-2161.
[15] Orrú CD, Yuan J, Appleby BS, Li B, Li Y, Winner D, Wang Z, Zhan YA, Rodgers M, Rarick J, Wyza RE, Joshi T, Wang GX, Cohen ML, Zhang S, Groveman BR, Petersen RB, Ironside JW, Quiñones-Mateu ME, Safar JG, Kong Q, Caughey B, Zou WQ. Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease[J]. Sci Transl Med, 2017, 9:eaam7785.
[16] Xiao K, Yang X, Zhou W, Chen C, Shi Q, Dong X. Validation and application of skin RT-QuIC to patients in China with probable CJD[J]. Pathogens, 2021, 10:1642.
[17] Orrú CD, Bongianni M, Tonoli G, Ferrari S, Hughson AG, Groveman BR, Fiorini M, Pocchiari M, Monaco S, Caughey B, Zanusso G. A test for Creutzfeldt-Jakob disease using nasal brushings[J]. N Engl J Med, 2014, 371:519-529.
[18] Bongianni M, Orrù C, Groveman BR, Sacchetto L, Fiorini M, Tonoli G, Triva G, Capaldi S, Testi S, Ferrari S, Cagnin A, Ladogana A, Poleggi A, Colaizzo E, Tiple D, Vaianella L, Castriciano S, Marchioni D, Hughson AG, Imperiale D, Cattaruzza T, Fabrizi GM, Pocchiari M, Monaco S, Caughey B, Zanusso G. Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples[J]. JAMA Neurol, 2017, 74:155-162.
[19] Jones SM, Lazar EB, Porter AL, Prusinski CC, Brier MR, Bucelli RC, Day GS. Real-time quaking-induced conversion assays for prions:applying a sensitive but imperfect test in clinical practice[J]. Eur J Neurol, 2023.[Epub ahead of print]
[20] Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High Consequence Pathogens and Pathology (DHCPP). CDC's diagnostic criteria for Creutzfeldt Jakob disease (CJD), 2018[DB/OL]. 2018(2018-08-15)[2023-04-10]. https://www. cdc.gov/prions/cjd/diagnostic criteria.html.
[21] Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwind MD, Green A, Haïk S, Kovacs GG, Ladogana A, Llorens F, Mead S, Nishida N, Pal S, Parchi P, Pocchiari M, Satoh K, Zanusso G, Zerr I. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease[J]. Lancet Neurol, 2021, 20:235-246.

选择文件类型/文献管理软件名称

选择包含的内容

2 应重视实时震动诱导转化技术在克-雅病临床诊断中的应用

Application value of real-time quaking-induced conversion technology in clinical diagnosis of Creutzfeldt-Jakob disease

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	佟志勇. 颅内动脉瘤与脑血管重建术[J]. 中国现代神经疾病杂志, 2024, 24(8): 595-598.
[2]	佟志勇. 脑血管重建术历史沿革[J]. 中国现代神经疾病杂志, 2024, 24(8): 599-605.
[3]	金凌骥, 胡俊文, 李寅, 王林. 复杂颅内动脉瘤的颅内-颅内血管搭桥术[J]. 中国现代神经疾病杂志, 2024, 24(8): 606-612.
[4]	刘佩玺, 史源, 朱巍. 血流导向时代颅内全域脑血管搭桥术治疗颅内动脉瘤之应用方略[J]. 中国现代神经疾病杂志, 2024, 24(8): 613-618.
[5]	张峰, 孟凡刚. 帕金森病自主神经功能障碍丘脑底核脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 510-515.
[6]	吴桂智, 田宏. Meige综合征脑深部电刺激术治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(7): 516-521.
[7]	孟凡刚, 张建国. 耳后磨骨槽技术在脑深部电刺激术中的应用[J]. 中国现代神经疾病杂志, 2024, 24(7): 522-524.
[8]	陈琳, 潘华. 功能性震颤的电生理诊断[J]. 中国现代神经疾病杂志, 2024, 24(7): 573-578.
[9]	魏俊吉, 常健博. 深入基层医院普及神经外科重症管理理念[J]. 中国现代神经疾病杂志, 2024, 24(6): 403-406.
[10]	史若琳, 高秀洁, 崔家宁, 邵妍, 谢璐霜, 刘毅. 5-羟色胺与帕金森病非运动症状研究进展[J]. 中国现代神经疾病杂志, 2024, 24(6): 497-501.
[11]	李海峰. 在进入靶向治疗的时代激素仍然是重症肌无力治疗的基础[J]. 中国现代神经疾病杂志, 2024, 24(5): 295-307.
[12]	许鸿嘉, 舒崖清, 王蘋, 李蕃, 许顺良, 邱伟, 马晓宇. 抗水通道蛋白4抗体阳性视神经脊髓炎谱系疾病诊断与治疗进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 308-314.
[13]	黄瑀, 廖金池, 舒崖清. 抗N-甲基-D-天冬氨酸受体脑炎睡眠障碍研究进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 315-319.
[14]	刘彩云, 金涛. 树突状细胞在多发性硬化免疫治疗中的应用[J]. 中国现代神经疾病杂志, 2024, 24(5): 320-330.
[15]	王军成, 赵岳阳, 杨强, 蒯涛, 潘亚文. HMGB1基因调控胶质瘤恶性生物学行为研究进展[J]. 中国现代神经疾病杂志, 2024, 24(5): 391-397.

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 应重视实时震动诱导转化技术在克-雅病临床诊断中的应用

Application value of real-time quaking-induced conversion technology in clinical diagnosis of Creutzfeldt-Jakob disease

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价